| 000 | 01502nam a2200313 a 4500 | ||
|---|---|---|---|
| 001 | EDZ0000091967 | ||
| 003 | StDuBDS | ||
| 005 | 20240216142723.0 | ||
| 006 | m||||||||d|||||||| | ||
| 007 | cr|||||||||||| | ||
| 008 | 120704s2012 nyua fo| 001 0 eng d | ||
| 020 |
_a9780199968749 (ebook) : _cNo price |
||
| 040 |
_aStDuBDS _cStDuBDS _epn |
||
| 050 | 0 |
_aHD9665.5 _b.O94 2012 |
|
| 082 | 0 | 4 |
_a338.476157 _223 |
| 245 | 0 | 4 |
_aThe Oxford handbook of the economics of the biopharmaceutical industry _h[electronic resource] / _cedited by Patricia M. Danzon and Sean Nicholson. |
| 246 | 3 | 0 | _aEconomics of the biopharmaceutical industry |
| 260 |
_aNew York ; _aOxford : _bOxford University Press, _cc2012. |
||
| 300 |
_a1 online resource (xix, 597 p.) : _bill. |
||
| 520 | 8 | _aThis examination of the economics of the biopharmaceutical industry has 18 chapters by health economists. Part 1 examines the economics of biopharmaceutical innovation. Part 2 examines the market for biopharmaceuticals with chapters on prices and reimbursement in industrialised and developing countries. | |
| 588 | _aDescription based on print version record. | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 | _aPharmaceutical industry. | |
| 650 | 0 |
_aBiopharmaceutics _xEconomic aspects. |
|
| 700 | 1 |
_aDanzon, Patricia Munch, _d1946- |
|
| 700 | 1 | _aNicholson, Sean. | |
| 776 | 0 | 8 |
_iPrint version _z9780199742998 |
| 856 | 4 | 0 |
_3Oxford handbooks online _uhttp://dx.doi.org/10.1093/oxfordhb/9780199742998.001.0001 |
| 999 |
_c6967 _d6967 |
||